Wireva

Obesity Doctor Urges FDA Crackdown on Compounded GLP-1 Sellers

A leading obesity specialist calls for tighter enforcement against telehealth firms selling compounded weight-loss drugs, warning that patients face unverified ingredients and minimal clinical oversight.

This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.

Monitoring item. The full text is not distributed. Extract and source below.

A leading obesity specialist calls for tighter enforcement against telehealth firms selling compounded weight-loss drugs, warning that patients face unverified ingredients and minimal clinical oversight.

Same event, other desks

Story file →